Cite
HARVARD Citation
Jiang, Q. et al. (2023). Albumin-encapsulated HSP90-PROTAC BP3 nanoparticles not only retain protein degradation ability but also enhance the antitumour activity of BP3 in vivo. Journal of drug targeting. pp. 411-420. [Online].